Biomedical Catalyst 2022 Round 2: Industry-led R&D

UK registered SMEs can apply for a share of up to £25 million to develop innovative solutions to health and healthcare challenges. This funding is from Innovate UK.

Competition opens: Monday 15 August 2022

Competition closes: Wednesday 12 October 2022 11:00am (BST)

Briefing Event: Tuesday 23rd August 2022 – 11:30 (BST) – Click here to join

Your project can focus on:

  • disease prevention and proactive management of health and chronic conditions
  • earlier and better detection and diagnosis of disease, leading to better patient outcomes
  • tailored treatments that either change the underlying disease or offer potential cures
  • transforming the delivery of healthcare

This list is not intended to be exhaustive.

The Industry led research and development (R&D) stream of the Biomedical Catalyst programme supports pre-market R&D projects. Applicants must be able to demonstrate existing evidence of commercial and technical feasibility.

Applications must show how they will improve the competitiveness and productivity of at least one UK SME involved in the project.

Project size

Your project’s total costs must be between £150,000 and £4 million. The total grant cannot exceed £2 million.

For more information and to apply please click here

MediWales Supporters:

Subscribe to our Mediwales newsletter